Monitoring of in vitro fat digestion by electron paramagnetic resonance spectroscopy

Pharmaceutical Research

Volumn 23, Issue 9, 2006, Pages 2024-2029

  Rübe, Andrea ^a   Klein, Sandra ^a   Mäder, Karsten ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

EPR; Lipid based drug delivery systems; Lipolysis

Indexed keywords

AMINE OXIDE; BUFFER; DIACYLGLYCEROL; GLYCEROL DIOLEATE; LIPID; OLEIC ACID; OLIVE OIL; PHARMACEUTICAL VEHICLES AND ADDITIVES; PHOSPHATE; TEMPOL; TRIOLEIN; VEGETABLE OIL;

ARTICLE; CHEMISTRY; ELECTRON SPIN RESONANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; MICELLE; SPIN LABELING; THIN LAYER CHROMATOGRAPHY;

BUFFERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; CYCLIC N-OXIDES; DIGLYCERIDES; ELECTRON SPIN RESONANCE SPECTROSCOPY; HYDROLYSIS; LIPIDS; MICELLES; OLEIC ACID; PHARMACEUTIC AIDS; PHOSPHATES; PLANT OILS; SPIN LABELS; TRIOLEIN;

EID: 33750595542     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9069-3     Document Type: Article

References (24)

1. P. P. Constantinides. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 12:1561-1572 (1995).
2. W. N. Charman, C. J. H. Porter, S. Mithani, and J. B. Dressman. Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J. Pharm. Sci. 86:269-282 (1997).
3. S. M. Khoo, A. J. Humberstone, C. J. H. Porter, G. A. Edwards, and W. N. Charman. Formulation design and bioavailability assessment of lipophilic self-emulsifying formulations of halofantrine. Int. J. Pharm. 167:155-164 (1998).
4. K. J. MacGregor, J. K. Embleton, J. E. Lacy, E. A. Perry, L. J. Solomon, H. Segger, and C. W. Pouton. Influence of lipolysis on drug absorption from the gastrointestinal tract. Adv. Drug Del. Rev. 25:33-46 (1997).
5. A. M. Kaukonen, B. J. Boyd, C. J. H. Porter, and W. N. Charman. Drug solubilization behaviour during in vitro digestion of simple triglyceride lipid solution formulations. Pharm. Res. 21:245-253 (2004).
6. A. M. Kaukonen, B. J. Boyd, W. N. Charman, and C. J. H. Porter. Drug solubilization behaviour during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids. Pharm. Res. 21:254-260 (2004).
7. N. H. Zangenberg, A. Mullertz, H. Gjelstrup Kristensen, and L. Hovgaard. A dynamic in vitro lipolysis model. II. Evaluation of the model. Eur. J. Pharm. Sci. 14:237-244 (2001).
8. J. E. Staggers, O. Hernell, R. J. Stafford, and M. C. Carey. PhysicalYchemical behaviour of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behaviour and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry. 29:2028-2040 (1990).
9. O. Hernell, J. E. Staggers, and M. C. Carey. Physical-chemical behaviour of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry. 29:2041-2056 (1990).
10. L. Sek, C. J. H. Porter, and W. N. Charman. Characterisation and quantification of medium chain and long chain triglycerides and their in situ densitometric analysis. J. Pharm. Biomed. Anal. 25:651-661 (2001).
11. L. Sek, C. J. H. Porter, A. M. Kaukonen, and W. N. Charman. Evaluation of the in-vitro profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J. Pharm. Pharmacol. 54:29-41 (2002).
12. N. H. Zangenberg, A. Mullertz, H. Gjelstrup Kristensen, and L. Hovgaard. A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. Eur. J. Pharm. Sci. 14:115-122 (2001).
13. C. J. H. Porter, A. M. Kaukonen, A. Taillardat-Bertschinger, B. J. Boyd, J. M. O'Connor, G. A. Edwards, and W. N. Charman. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J. Pharm. Sci. 93:1110-1121 (2003).
14. S. Klein. Optimierung eines Pankreatin-Assays als prädiktives in vitro Modell zur Bioverfügbarkeit von Wirkstoffformulierungen. Diploma thesis, Martin-Luther-Universität Halle/Wittenberg (2006).
15. D. J. Lurie and K. Mäder. Monitoring drug delivery processes by EPR and related techniques - principles and applications. Adv. Drug Deliv. Rev. 57:1171-1190 (2005).
16. D. R. Duling. Simulation of multiple isotropic spin trap EPR spectra. J. Magn. Reson. B. 104:105-110 (1994).
17. K. Jores, W. Mehnert, and K. Mäder. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study. Pharm. Res. 20:1274-1283 (2003).
18. T. Ymaguchi, S. Itai, H. Hayashi, S. Soda, A. Hamada, and H. Utsumi. In vivo ESR studies on phamacokinetics and metabolism of parenteral lipid emulsion in living mice. Pharm. Res. 13(5):729-733 (1996).
19. J. Sjövall. On the concentration of bile acids in the human intestine during absorption. Acta Physiol. Scand. 46:339-345 (1959).
20. O. Fausa. Duodenal bile acids after a test meal. Scand. J. Gastroenterol. 9:567-570 (1974).
21. H. Westergaard. Duodenal bile acid concentrations in fat malabsorption syndromes. Scand. J. Gastroenterol. 12:115-122 (1977).
22. M. Rautereau, A. Bisalli, and J. C. Ranbaud. Étude de la phase aqueuse intra-jéjunale des sels biliaires et des lipides au cours de la digestion d'un repas standard chez le sujet normal. Gastroenterol. Clin. Biol. 5:417-425 (1981).
23. A. Lindahl, A. L. Ungell, L. Knutson, and H. Lennernas. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm. Res. 14:497-502 (1997).
24. V. Lebet, E. Arrigoni, and R. Amadò. Digestion procedure using mammalian enzymes to obtain substrates for in vitro fermentation studies. Lebensm-Wiss u-Technol. 31:509-515 (1998).